View in EDS

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.

Saved in:
Bibliographic Details
Title: Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.
Authors: Fazal O; From the Department of Ophthalmology (O.F., D.D.B., C.C., N.A.P.), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA; Harvard Medical School (O.F.), Boston, Massachusetts, USA., Loya A; Cullen Eye Institute (A.L., A.F.A., C.Y.W.), Houston, Texas, USA., Muayad J; College of Medicine (J.M.), Texas A&M University, Houston, Texas, USA., Alsoudi AF; Cullen Eye Institute (A.L., A.F.A., C.Y.W.), Houston, Texas, USA., Bordbar DD; From the Department of Ophthalmology (O.F., D.D.B., C.C., N.A.P.), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA., Chaaya C; From the Department of Ophthalmology (O.F., D.D.B., C.C., N.A.P.), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA., Weng CY; Cullen Eye Institute (A.L., A.F.A., C.Y.W.), Houston, Texas, USA., Rahimy E; Department of Ophthalmology (E.R.), Byers Eye Institute, Horngren Family Vitreoretinal Center, Stanford University School of Medicine, Palo Alto, California, USA; Department of Ophthalmology (E.R.), Palo Alto Medical Foundation, Palo Alto, California, USA., Patel NA; From the Department of Ophthalmology (O.F., D.D.B., C.C., N.A.P.), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: nimeshpatel300@gmail.com.
Source: American journal of ophthalmology [Am J Ophthalmol] 2026 Jun 23; Vol. 290, pp. 246-251. Date of Electronic Publication: 2026 Jun 23.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42336230
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fazal+O%22">Fazal O</searchLink>; From the Department of Ophthalmology (O.F., D.D.B., C.C., N.A.P.), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA; Harvard Medical School (O.F.), Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Loya+A%22">Loya A</searchLink>; Cullen Eye Institute (A.L., A.F.A., C.Y.W.), Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Muayad+J%22">Muayad J</searchLink>; College of Medicine (J.M.), Texas A&M University, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Alsoudi+AF%22">Alsoudi AF</searchLink>; Cullen Eye Institute (A.L., A.F.A., C.Y.W.), Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Bordbar+DD%22">Bordbar DD</searchLink>; From the Department of Ophthalmology (O.F., D.D.B., C.C., N.A.P.), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Chaaya+C%22">Chaaya C</searchLink>; From the Department of Ophthalmology (O.F., D.D.B., C.C., N.A.P.), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Weng+CY%22">Weng CY</searchLink>; Cullen Eye Institute (A.L., A.F.A., C.Y.W.), Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Rahimy+E%22">Rahimy E</searchLink>; Department of Ophthalmology (E.R.), Byers Eye Institute, Horngren Family Vitreoretinal Center, Stanford University School of Medicine, Palo Alto, California, USA; Department of Ophthalmology (E.R.), Palo Alto Medical Foundation, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Patel+NA%22">Patel NA</searchLink>; From the Department of Ophthalmology (O.F., D.D.B., C.C., N.A.P.), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: nimeshpatel300@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370500%22">American journal of ophthalmology</searchLink> [Am J Ophthalmol] 2026 Jun 23; Vol. 290, pp. 246-251. <i>Date of Electronic Publication: </i>2026 Jun 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0370500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-1891 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200029394%22">00029394 </searchLink><i>NLM ISO Abbreviation: </i>Am J Ophthalmol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42336230
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ajo.2026.06.037
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 246
    Titles:
      – TitleFull: Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fazal O
      – PersonEntity:
          Name:
            NameFull: Loya A
      – PersonEntity:
          Name:
            NameFull: Muayad J
      – PersonEntity:
          Name:
            NameFull: Alsoudi AF
      – PersonEntity:
          Name:
            NameFull: Bordbar DD
      – PersonEntity:
          Name:
            NameFull: Chaaya C
      – PersonEntity:
          Name:
            NameFull: Weng CY
      – PersonEntity:
          Name:
            NameFull: Rahimy E
      – PersonEntity:
          Name:
            NameFull: Patel NA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 06
              Text: 2026 Jun 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-1891
          Numbering:
            – Type: volume
              Value: 290
          Titles:
            – TitleFull: American journal of ophthalmology
              Type: main
ResultId 1